MSCs have beneficial effects in ARDS animal models, such as reducing lung injury and maintaining alveolar‐endothelial barrier homeostasis mediated by TGF‐β1, IDO, NO, IL‐1RA, KGF and IL‐10.6, 7. This evidence concerns the gene TGFB1 and acute respiratory distress syndrome.